Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Anuh Pharma has informed that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company at their meeting held on 6th January, 2023, approved the appointment of Hemant Auti having Membership no. A51703 with effect from 7, January, 2023 as the Company Secretary (CO) and Compliance Officer (CO) of the Company and shall be designated as the Key Managerial Personnel of the Company. Brief profile of Hemant Auti is annexed as an Annexure – A.
The above information is a part of company’s filings submitted to BSE.
